A Clinical Trial to Evaluate the Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination Treatment in Patients With Concomitant Hypertension and Hyperlipidemia
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 265 participants.
Also called NCT03009487
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 265 participants
- Registry
-
NCT03009487
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT03009487. Randomized; double masking; primary purpose treatment. Start 2017-01 (actual); primary completion 2018-04 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Clinical Trial to Evaluate the Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination Treatment in Patients With Concomitant Hypertension and Hyperlipidemia
- Condition
- Hypertension
- Condition
- Hyperlipidemias
- Intervention (Drug)
- Amlodipine/Olmesartan 10/40mg (Combination drug), Rosuvastatin 20mg
- Intervention (Drug)
- Olmesartan 40 mg, Rosuvastatin 20mg
- Intervention (Drug)
- Amlodipine/Olmesartan 10/40mg (Combination drug)
- Lead sponsor
- Daewoong Pharmaceutical Co. LTD.
Record details
- Record id
cardio:ct-nct03009487- Content hash
87972eebbd1ae5805d161b4d05e572a4fa6897ecfab771d4c738330a0ce4bd84